Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression

Abstract Background Aging is accompanied by a dramatic decline in the interleukin (IL)-2 production capacity of human immune cells, thus making seniors more susceptible to a variety of age-related diseases. A common cause of impaired cytokine production in advanced age is a deficiency of the essenti...

Full description

Bibliographic Details
Main Authors: Bastian Robinson Baarz, Thea Laurentius, Jana Wolf, Inga Wessels, Leo Cornelius Bollheimer, Lothar Rink
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Immunity & Ageing
Subjects:
Online Access:https://doi.org/10.1186/s12979-022-00295-8
_version_ 1811297502110941184
author Bastian Robinson Baarz
Thea Laurentius
Jana Wolf
Inga Wessels
Leo Cornelius Bollheimer
Lothar Rink
author_facet Bastian Robinson Baarz
Thea Laurentius
Jana Wolf
Inga Wessels
Leo Cornelius Bollheimer
Lothar Rink
author_sort Bastian Robinson Baarz
collection DOAJ
description Abstract Background Aging is accompanied by a dramatic decline in the interleukin (IL)-2 production capacity of human immune cells, thus making seniors more susceptible to a variety of age-related diseases. A common cause of impaired cytokine production in advanced age is a deficiency of the essential micronutrient zinc. Nevertheless, the molecular mechanisms underlying a zinc deficiency-induced decrease in IL-2 production have not yet been satisfactorily elucidated. Recent animal and in vitro data suggested that the transcription factor cAMP-responsive element modulator (CREM) $$\alpha$$ α plays a critical role in T cells´ disturbed IL-2 production in suboptimal zinc conditions. However, its role in the human aging process and the possibility of influencing this detrimental process by short-term zinc supplementation have not yet been evaluated. Results Comparing peripheral lymphocytes of 23 young and 31 elderly subjects with either high, intermediate, or deficient zinc status, we observed zinc-dependent regulation of the IL-2 production mediated by the transcription factor CREM $$\alpha$$ α . For the first time in humans, we report a mutual relationship between low zinc levels, high CREM $$\alpha$$ α expression, subsequent impaired IL-2 production, and vice versa. Remarkably, an average of only 6 days of in vivo zinc supplementation to zinc-deficient seniors was sufficient to rapidly improve zinc status, reverse CREM $$\alpha$$ α overexpression, and counteract subsequent low IL-2 production rates. Conclusions Our ex vivo and in vivo data identify zinc deficiency-mediated CREM $$\alpha$$ α overexpression as a key cellular mechanism underlying impaired IL-2 production in the elderly and point toward the use of zinc as a rapidly immune-enhancing add-on nutraceutical in geriatric therapy. Graphical abstract During the aging process, there is a progressive decrease in zinc status, which in turn leads to overexpression of the transcription factor CREM $$\mathrm{\alpha }$$ α in peripheral lymphocytes. CREMα is a negative regulator of the IL-2 gene, the overexpression of which dramatically limits adequate IL-2 production. This deleterious mechanism can be counteracted by short-term oral zinc administration, which can adjust IL-2 production in old, zinc-deficient individuals to a level similar to that of young adults.
first_indexed 2024-04-13T06:05:16Z
format Article
id doaj.art-81bb2ddacd444642ab05827915faf80f
institution Directory Open Access Journal
issn 1742-4933
language English
last_indexed 2024-04-13T06:05:16Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Immunity & Ageing
spelling doaj.art-81bb2ddacd444642ab05827915faf80f2022-12-22T02:59:16ZengBMCImmunity & Ageing1742-49332022-08-0119111610.1186/s12979-022-00295-8Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppressionBastian Robinson Baarz0Thea Laurentius1Jana Wolf2Inga Wessels3Leo Cornelius Bollheimer4Lothar Rink5Institute of Immunology, Faculty of Medicine, RWTH Aachen University HospitalDepartment of Geriatric Medicine, Faculty of Medicine, RWTH Aachen University HospitalInstitute of Immunology, Faculty of Medicine, RWTH Aachen University HospitalInstitute of Immunology, Faculty of Medicine, RWTH Aachen University HospitalDepartment of Geriatric Medicine, Faculty of Medicine, RWTH Aachen University HospitalInstitute of Immunology, Faculty of Medicine, RWTH Aachen University HospitalAbstract Background Aging is accompanied by a dramatic decline in the interleukin (IL)-2 production capacity of human immune cells, thus making seniors more susceptible to a variety of age-related diseases. A common cause of impaired cytokine production in advanced age is a deficiency of the essential micronutrient zinc. Nevertheless, the molecular mechanisms underlying a zinc deficiency-induced decrease in IL-2 production have not yet been satisfactorily elucidated. Recent animal and in vitro data suggested that the transcription factor cAMP-responsive element modulator (CREM) $$\alpha$$ α plays a critical role in T cells´ disturbed IL-2 production in suboptimal zinc conditions. However, its role in the human aging process and the possibility of influencing this detrimental process by short-term zinc supplementation have not yet been evaluated. Results Comparing peripheral lymphocytes of 23 young and 31 elderly subjects with either high, intermediate, or deficient zinc status, we observed zinc-dependent regulation of the IL-2 production mediated by the transcription factor CREM $$\alpha$$ α . For the first time in humans, we report a mutual relationship between low zinc levels, high CREM $$\alpha$$ α expression, subsequent impaired IL-2 production, and vice versa. Remarkably, an average of only 6 days of in vivo zinc supplementation to zinc-deficient seniors was sufficient to rapidly improve zinc status, reverse CREM $$\alpha$$ α overexpression, and counteract subsequent low IL-2 production rates. Conclusions Our ex vivo and in vivo data identify zinc deficiency-mediated CREM $$\alpha$$ α overexpression as a key cellular mechanism underlying impaired IL-2 production in the elderly and point toward the use of zinc as a rapidly immune-enhancing add-on nutraceutical in geriatric therapy. Graphical abstract During the aging process, there is a progressive decrease in zinc status, which in turn leads to overexpression of the transcription factor CREM $$\mathrm{\alpha }$$ α in peripheral lymphocytes. CREMα is a negative regulator of the IL-2 gene, the overexpression of which dramatically limits adequate IL-2 production. This deleterious mechanism can be counteracted by short-term oral zinc administration, which can adjust IL-2 production in old, zinc-deficient individuals to a level similar to that of young adults.https://doi.org/10.1186/s12979-022-00295-8AgingCytokinesInterleukin-2Dietary supplementsTrace elementZinc
spellingShingle Bastian Robinson Baarz
Thea Laurentius
Jana Wolf
Inga Wessels
Leo Cornelius Bollheimer
Lothar Rink
Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression
Immunity & Ageing
Aging
Cytokines
Interleukin-2
Dietary supplements
Trace element
Zinc
title Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression
title_full Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression
title_fullStr Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression
title_full_unstemmed Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression
title_short Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression
title_sort short term zinc supplementation of zinc deficient seniors counteracts cremα mediated il 2 suppression
topic Aging
Cytokines
Interleukin-2
Dietary supplements
Trace element
Zinc
url https://doi.org/10.1186/s12979-022-00295-8
work_keys_str_mv AT bastianrobinsonbaarz shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression
AT thealaurentius shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression
AT janawolf shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression
AT ingawessels shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression
AT leocorneliusbollheimer shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression
AT lotharrink shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression